Skip to content
Search

Latest Stories

Primary care director confirms community pharmacy to be used in scale-up of Covid-19 vaccination next week

Amid reports of the first sites being identified as centres for national rollout of the Astra Zeneca Covid-19 jabs, Dr Nikki Kanani, director for Primary Care, NHS England and NHS Improvement has confirmed on social media that the latest coronavirus vaccination programme would be scaled up in community pharmacies from next week.

Replying to a tweet from pharmacist Graham Phillips as to when the NHS was planning to roll out the Oxford vaccine via community pharmacy, she said: “From next week, in comm(unity) pharm(acy), scaling up as per other LVS sites.”


Dr Kanani also added a link to a document that gave further details on how community pharmacy would be offering the coronavirus vaccination programme as a local enhanced service (LES).

The document prepared before MHRA’s approval of the Oxford/Astra Zeneca vaccine for Covid-19 states that one of the aims of this service is to maximise uptake of Covid-19 vaccine in identified at risk groups by using community pharmacy to supplement service provision by general practice Primary Care Networks (PCNs) in local vaccination services (LVS) or through larger vaccination centres where a need is identified by regional commissioners.

It noted that patients who have booked appointments with the National Booking Service (NBS) will have eligibility confirmed prior to booking. Pharmacy Contractors must only administer vaccinations to patients who have been offered a vaccination through the national call/recall service.

NHS England said it has already written to some community pharmacy contractors to prepare rolling out the vaccination programme as part of the Local Enhanced Service for community pharmacy.

The letter dated Dec 28 stated: "We are writing to confirm that your LVS designated site should be stood up in the week beginning January 4 2021 in order to be ready to administer vaccines following a delivery of the vaccine from January 11 2021."

“Community pharmacies are already a key part of rolling out the vaccination through existing sites and pharmacy led sites will begin vaccinating in the coming days and weeks,” NHS England told Pharmacy Business on Monday.

Vaccines offered under this service must be received, stored, and prepared in line with any conditions set by the MHRA in relation to each vaccine, and in accordance with the manufacturer’s, Health Education England’s and NHS England and NHS Improvement’s

instructions and associated Standard Operating Procedures.

Receipt, storage and preparation of vaccines used under this service should also be undertaken with appropriate clinical oversight and with regard to governance arrangements in place for the service.

Contractors must agree with the Commissioner as part of the site Designation

Process the number of vaccinations they can deliver each week.

A minimum of 1,000 vaccinations each week is required as set out in the original Site Designation documents.

Pharmacy contractors may be required to offer this service for seven days a week, from 8am to 8pm, including on bank holidays, as agreed as part of becoming a Designated Site.

A payment £25.16 will be made for two service payments of £12.58 each and is intended to reflect the two vaccinations per patient which make up the course of the treatment.

Claims for payments for this service should be made each month via the Manage

Your Service (MYS) platform provided by the NHS Business Services Authority.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less